Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

NCT03293485 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Intra-abdominal Infection
Complicated Urinary Tract Infection

Interventions

DRUG: Imipenem+Cilastatin/Relebactam

Sponsor

Merck Sharp & Dohme LLC